
Melanotan 2 (MT-2) is a synthetic analog of alpha-MSH that stimulates melanin production with minimal UV exposure. It has no FDA approval for any indication and carries significant side effects requiring careful management. This is not medical advice.
| Parameter |
Detail |
| Loading dose |
500 mcg/day (start at 250 mcg for 2-3 days) |
| Maintenance dose |
500 mcg, 2x per week |
| Route |
Subcutaneous injection |
| Timing |
Before bed (sleep through nausea) |
| Loading duration |
2-3 weeks daily |
| UV exposure |
10-15 min daily during loading |
| Vial size |
10 mg |
| Reconstitution |
2 mL BAC water (5,000 mcg/mL) |
| Draw amount |
10 units for 500 mcg |
| Storage |
Refrigerate, protect from light, 28 days |
Melanotan 2 is not in the standard cheat sheet — this is a community protocol based on decades of underground use and limited clinical data.
For the full Melanotan 2 profile, vendor pricing, and safety protocols, see our Melanotan 2 peptide page.
Cycling Details
MT-2 follows a distinct two-phase approach:
Loading (Weeks 1-3): 500 mcg daily (start at 250 mcg for first 2-3 days to assess nausea). Combined with 10-15 minutes daily UV exposure. Goal: reach desired tan depth.
Maintenance (Week 4+): 500 mcg twice per week. Maintain established tan with minimal ongoing UV. Continue as long as tan maintenance is desired.
First-time users typically need 3 weeks loading. Returning users respond faster (2 weeks). Competition prep may extend loading to 4-6 weeks.
Routes of Administration
Subcutaneous (standard): Abdomen, thigh, or arm. Many inject before bed to sleep through nausea. Rotate injection sites. Volume is typically 0.1 mL with insulin syringe.
Intranasal (alternative): Less common, absorption is less predictable. May cause nasal irritation. Requires higher doses than subcutaneous.
Not effective oral — peptide degraded by stomach acid.
Reconstitution Quick Reference

| Vial Size |
BAC Water |
Concentration |
250 mcg |
500 mcg |
| 10 mg |
2 mL |
5,000 mcg/mL |
5 units |
10 units |
Math: 10,000 mcg / 2 mL = 5,000 mcg/mL. 500 mcg / 5,000 = 0.1 mL = 10 units. Refrigerate after mixing, protect from light, use within 30 days.
For step-by-step instructions, see the Melanotan 2 Reconstitution Guide.
Where These Numbers Come From
MT-2 has some human clinical data, primarily from sexual dysfunction studies rather than tanning.
Wessells et al. (2000) tested intranasal MT-2 at 0.025 mg/kg (approximately 1.75 mg for 70 kg person) in a Phase II erectile dysfunction trial with significant efficacy (PMID 11035391). Dorr et al. (1996) published the Phase I clinical study of MT-II demonstrating melanotropic activity (PMID 8637402).
The loading/maintenance pattern evolved from decades of underground use: early protocols (1990s) used higher doses with more side effects; current protocols have been refined through community experience. The community settled on 250-500 mcg range as the sweet spot for effective MC1R saturation without excessive nausea.
Stacking Protocols
MT-2 is rarely stacked due to its unique mechanism and side effect profile.
| Stack |
MT-2 Dose |
Notes |
| UV exposure |
500 mcg per protocol |
Essential — not optional |
| Sun protection |
Standard |
MT-2 tan does NOT eliminate need for SPF |
Do NOT stack with PT-141 — both work through melanocortin receptors, redundant rather than synergistic. Choose one based on primary goal (tanning vs sexual enhancement). Do NOT stack with Melanotan-1 — unnecessary overlap.
Side Effects & Safety
- Nausea — 80-90% of users, especially during loading. Peaks 2-4 hours post-injection, lasts 4-6 hours. Bedtime dosing helps
- Facial flushing — within 30-60 minutes, lasts 1-2 hours
- Appetite suppression — significant during loading, can exceed 50% reduction
- Libido increase — pronounced; led to PT-141 development
- Fatigue/lethargy — especially first week
- Mole/freckle darkening — potentially permanent; requires dermatological monitoring
- Injection site darkening — localized hyperpigmentation
- Mood changes — irritability reported by some during loading
Managing nausea: Start at 100-250 mcg, inject before bed, empty stomach, consider anti-nausea medication (ondansetron), increase dose gradually.
Frequently Asked Questions
What is the standard Melanotan 2 loading dose?
500 mcg daily for 2-3 weeks. Start at 250 mcg for the first 2-3 days to assess nausea tolerance before increasing to full loading dose.
How long is the loading phase?
2-3 weeks with daily injections. Some extend to 4 weeks for very pale skin or slower responders.
What's the maintenance dose?
500 mcg twice per week after loading. Adjust frequency based on response and desired tan maintenance.
How do I prevent nausea?
Start low (100-250 mcg), inject before bed, empty stomach, consider anti-nausea medication, and increase gradually over several days.
How much UV exposure do I need?
Minimal — even 10-15 minutes of sunlight can trigger significant melanin production. Many achieve substantial tans with just incidental sun exposure.
Can Melanotan 2 cause permanent side effects?
Most effects are temporary (nausea, flushing, appetite). The main concern is potentially permanent mole/freckle changes requiring dermatological monitoring.
What's the difference between Melanotan 1 and Melanotan 2?
MT-2 is more potent for tanning with additional libido and appetite effects. MT-1 is more selective (MC1R only), has fewer side effects, requires more UV, and is FDA-approved for EPP. See our MT-1 vs MT-2 comparison.
References
| Citation |
Topic |
PMID |
| Wessells et al., Int J Impot Res (2000) |
Phase II trial for ED, 0.025mg/kg dosing, efficacy |
11035391 |
| Dorr et al., Photochem Photobiol (1996) |
Phase I clinical study of MT-II, melanotropic activity |
8637402 |
| Hadley & Dorr, Peptides (2005) |
Discovery of melanocortin regulation of sexual function |
15996790 |
| Hadley & Dorr, Peptides (2006) |
Melanocortin peptide therapeutics milestones |
16412534 |
| Safarinejad, J Sex Med (2008) |
Bremelanotide salvage of sildenafil failures, RCT |
18206919 |
For educational and research purposes only. This is not medical advice. Melanotan 2 is not FDA-approved for any indication and carries significant side effects.